Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Year of publication
Document Type
- Journal article (11)
- Doctoral Thesis (1)
Keywords
- echocardiography (4)
- amyloidosis (2)
- deformation (2)
- ejection fraction (2)
- prognosis (2)
- 5IA-SPECT (1)
- Aortenstenose (1)
- Aortic valve stenosis (1)
- B-scan-Ultraschallkardiographie (1)
- CVID (1)
- Chronic heart-failure (1)
- Doppler-Echokardiographie (1)
- ECMO (1)
- European Society for Immunodeficiencies (ESID) (1)
- Fibrose (1)
- German PID-NET registry (1)
- Herzfunktion (1)
- Herzklappenfehler (1)
- Herzmuskel (1)
- INR rebound (1)
- IgG substitution therapy (1)
- PET/CT (1)
- PID prevalence (1)
- PRRT (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Prevalence (1)
- Prognostic impact (1)
- RADS (1)
- Risk-factors (1)
- SARS-CoV2 (1)
- SSTR-RADS (1)
- Septal bulge (1)
- Strain Rate Imaging (1)
- Ultraschallkar (1)
- Valvular heart-desease (1)
- aortic valve stenosis (AS) (1)
- blood pressure monitoring (1)
- calcium imaging (1)
- cardiac amyloidosis (1)
- cardiac transplantation (1)
- case report (1)
- cholinergic activity (1)
- cognitive decline (1)
- corticoid (1)
- death rates (1)
- diagnostic medicine (1)
- dobutamine stress echocardiography (1)
- dopamine acetylcholine (1)
- emergency (1)
- fibrosis (1)
- heart disease (1)
- hypertension (1)
- levodopa-induced dyskinesia (1)
- low-gradient AS (1)
- major bleeding (1)
- methylprednisolone (1)
- mild (1)
- mortality (1)
- neuroendocrine tumor (1)
- nicotinic receptors (1)
- peptide receptor radionuclide therapy (1)
- pharmacokinetics (1)
- phenprocoumon (1)
- primary immunodeficiency (PID) (1)
- pseudo-severe AS (1)
- pulse therapy (1)
- registry for primary immunodeficiency (1)
- regression analysis (1)
- reporting and data system (1)
- salvage therapy (1)
- statins (1)
- stem cell transplantation (1)
- therapy (1)
- tissue doppler (1)
- urgent surgery (1)
Institute
- Medizinische Klinik und Poliklinik I (6)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Klinik und Poliklinik für Nuklearmedizin (3)
- Medizinische Klinik und Poliklinik II (3)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (2)
- Neurologische Klinik und Poliklinik (2)
- Institut für Pharmakologie und Toxikologie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Kinderklinik und Poliklinik (1)
Patients in the early stage of hypertensive heart disease tend to have normal echocardiographic findings. The aim of this study was to investigate whether pathology-specific echocardiographic morphologic and functional parameters can help to detect subclinical hypertensive heart disease. One hundred ten consecutive patients without a history and medication for arterial hypertension (AH) or other cardiac diseases were enrolled. Standard echocardiography and two-dimensional speckle tracking -imaging analysis were performed. Resting blood pressure (BP) measurement, cycle ergometer test (CET), and 24-hour ambulatory BP monitoring (ABPM) were conducted. Patients were referred to "septal bulge (SB)" group (basal-septal wall thickness >= 2 mm thicker than mid-septal wall thickness) or "no-SB" group. Echocardiographic SB was found in 48 (43.6%) of 110 patients. In this SB group, 38 (79.2%) patients showed AH either by CET or ABPM. In contrast, in the no-SB group (n = 62), 59 (95.2%) patients had no positive test for AH by CET or ABPM. When AH was solely defined by resting BP, SB was a reasonable predictive sign for AH (sensitivity 73%, specificity 76%). However, when AH was confirmed by CET or ABPM the echocardiographic SB strongly predicted clinical AH (sensitivity 93%, specificity 86%). In addition, regional myocardial deformation of the basal-septum in SB group was significantly lower than in no-SB group (14 +/- 4% vs. 17 +/- 4%; P < .001). In conclusion, SB is a morphologic echocardiographic sign for early hypertensive heart disease. Sophisticated BP evaluation including resting BP, ABPM, and CET should be performed in all patients with an accidental finding of a SB in echocardiography.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.